Hangzhou Tigermed Consulting Cash Flow Reinvestment Rate
Hangzhou Tigermed Consulting cash flow reinvestment rate. Hangzhou Tigermed Consulting (300347) has a Cash Flow Reinvestment Rate of 0.15x as of September 2025, reinvesting CN¥72.75 Million (capex CN¥72.75 Million ) from operating cash flow of CN¥475.40 Million. Explore Hangzhou Tigermed Consulting debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hangzhou Tigermed Consulting (2009–2025)
Cash flow reinvestment rate of Hangzhou Tigermed Consulting from 2009 to 2025. Historical reinvestment intensity for Hangzhou Tigermed Consulting across 17 annual periods. Explore 300347 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Hangzhou Tigermed Consulting Cash Flow Reinvestment Rate by Year (2009–2025)
Hangzhou Tigermed Consulting cash flow reinvestment rate by year from 2009 to 2025. Year-by-year capital reinvestment analysis for Hangzhou Tigermed Consulting. For the full cash flow conversion analysis, see Hangzhou Tigermed Consulting cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.01x | CN¥1.13 Billion | CN¥1.12 Billion | CN¥214.37 Million | ▼ -74.7% |
| 2024 | 3.99x | CN¥4.38 Billion | CN¥1.10 Billion | CN¥356.55 Million | ▲ +148.6% |
| 2023 | 1.61x | CN¥1.85 Billion | CN¥1.15 Billion | CN¥313.76 Million | ▼ -2.1% |
| 2022 | 1.64x | CN¥2.23 Billion | CN¥1.36 Billion | CN¥448.60 Million | ▼ -6.8% |
| 2021 | 1.76x | CN¥2.51 Billion | CN¥1.42 Billion | CN¥368.62 Million | ▼ -13.1% |
| 2020 | 2.03x | CN¥2.02 Billion | CN¥998.68 Million | CN¥156.50 Million | ▲ +73.7% |
| 2019 | 1.17x | CN¥615.55 Million | CN¥527.56 Million | CN¥102.91 Million | ▲ +74.7% |
| 2018 | 0.67x | CN¥348.83 Million | CN¥522.24 Million | CN¥91.72 Million | ▼ -46.4% |
| 2017 | 1.25x | CN¥392.46 Million | CN¥314.97 Million | CN¥45.96 Million | ▼ -59.6% |
| 2016 | 3.08x | CN¥591.66 Million | CN¥191.91 Million | CN¥61.66 Million | ▲ +121.6% |
| 2015 | 1.39x | CN¥258.36 Million | CN¥185.73 Million | CN¥87.08 Million | ▲ +59.4% |
| 2014 | 0.87x | CN¥38.10 Million | CN¥43.66 Million | CN¥38.10 Million | ▲ +79.7% |
| 2013 | 0.49x | CN¥37.45 Million | CN¥77.10 Million | CN¥37.45 Million | ▼ -66.5% |
| 2012 | 1.45x | CN¥21.69 Million | CN¥14.98 Million | CN¥21.69 Million | ▲ +244.9% |
| 2011 | 0.42x | CN¥16.24 Million | CN¥38.69 Million | CN¥16.24 Million | ▲ +34.6% |
| 2010 | 0.31x | CN¥8.29 Million | CN¥26.59 Million | CN¥8.29 Million | ▼ -50.7% |
| 2009 | 0.63x | CN¥13.88 Million | CN¥21.95 Million | CN¥13.88 Million | — |